Handelsbanken Fonder’s Aerie Pharmaceuticals AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-13,051
Closed -$149K 1773
2021
Q3
$149K Hold
13,051
﹤0.01% 1665
2021
Q2
$209K Buy
+13,051
New +$224K ﹤0.01% 1690
2020
Q3
Sell
-440,551
Closed -$6.5M 1477
2020
Q2
$6.5M Sell
440,551
-62,449
-12% -$924K 0.05% 282
2020
Q1
$6.79M Buy
503,000
+130,000
+35% +$2.47M 0.15% 134
2019
Q4
$9.02M Buy
373,000
+65,000
+21% +$1.35M 0.16% 134
2019
Q3
$5.92M Sell
308,000
-77,800
-20% -$1.78M 0.12% 141
2019
Q2
$11.4M Sell
385,800
-10,000
-3% -$385K 0.21% 122
2019
Q1
$18.8M Buy
395,800
+2,500
+0.6% +$110K 0.36% 72
2018
Q4
$14.2M Buy
393,300
+63,300
+19% +$2.97M 0.29% 97
2018
Q3
$20.3M Buy
330,000
+25,000
+8% +$1.61M 0.38% 82
2018
Q2
$20.6M Buy
305,000
+45,000
+17% +$2.52M 0.4% 78
2018
Q1
$14.1M Buy
260,000
+130,000
+100% +$7.27M 0.28% 97
2017
Q4
$7.77M Hold
130,000
0.17% 111
2017
Q3
$6.32M Hold
130,000
0.15% 127
2017
Q2
$6.83M Buy
130,000
+57,000
+78% +$2.65M 0.17% 112
2017
Q1
$3.31M Buy
+73,000
New +$3.26M 0.09% 133
2016
Q1
Sell
-45,000
Closed -$1.1M 623
2015
Q4
$1.1M Buy
+45,000
New +$1.05M 0.02% 476

Other funds holding AERI

Handelsbanken Fonder's AERI Position: Q4 2021 in Review

Handelsbanken Fonder sold out of Aerie Pharmaceuticals (AERI) in Q4 2021, closing a stake of 13,051 shares — an estimated $149K sold.

Handelsbanken Fonder first reported a position in AERI in Q4 2015 and held it in 17 quarters. The position peaked at $20.6M in Q2 2018. 129 funds tracked by Wall St. Rank hold AERI as of Q4 2021.

  • Handelsbanken Fonder reported no remaining Aerie Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Handelsbanken Fonder sold 13,051 Aerie Pharmaceuticals shares in Q4 2021, an estimated $149K.
  • Handelsbanken Fonder first reported a position in Aerie Pharmaceuticals in Q4 2015 and held it in 17 quarters.
  • Handelsbanken Fonder's Aerie Pharmaceuticals position peaked at $20.6M in Q2 2018.
  • 129 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2021.

Based on Handelsbanken Fonder's 13F filing for Q4 2021, filed 8 Feb 2022.